Connect with us

Technology

Kamux Corporation’s Financial Statements Bulletin for January 1–December 31, 2023: Revenue grew and adjusted operating profit increased significantly during the fourth quarter

Published

3 years ago

on

Kamux Corporation, Financial Statement Release, 1.3.2024 at 9:00

HÄMEENLINNA, Finland, March 1, 2024 /PRNewswire/ — Kamux Corporation’s Financial Statements Bulletin for January 1—December 31, 2023: Revenue grew and adjusted operating profit increased significantly during the fourth quarter

This is a summary of Kamux Corporation’s Financial Statements Bulletin for January 1—December 31, 2023. The complete report is attached to this release and is also available at the company website at kamux.com.

The figures in parentheses refer to the comparison period, i.e., the same period in the previous year, unless stated otherwise.

October—December in brief

Revenue increased by 8.4%, totaling EUR 241.6 million (222.9)Gross profit increased by 23.4% to EUR 26.1 million (21.2), or 10.8% (9.5) of revenueAdjusted operating profit (EBIT) increased by 164.1% to EUR 5.5 million (2.1), or 2.3% (0.9) of revenueOperating profit (EBIT) increased by 176.9% to EUR 4.5 million (1.6), or 1.9% (0.7) of revenueThe number of cars sold increased by 11.4% to 16,354 cars (14,681)Like-for-like showroom revenue growth was 8.2% (-10.9)Basic and diluted earnings per share were EUR 0.06 (0.00)

January—December in brief

Revenue increased by 3.5%, totaling EUR 1,002.1 million (968.7)Gross profit increased by 9.0% to EUR 102.5 million (94.1), or 10.2% (9.7) of revenueAdjusted operating profit (EBIT) increased by 3.2% to EUR 18.0 million (17.5), or 1.8% (1.8) of revenueOperating profit (EBIT) decreased by -7.1% to EUR 15.8 million (17.0), or 1.6% (1.8) of revenueThe number of cars sold increased by 8.5% to 68,257 cars (62,922)Like-for-like showroom revenue growth was 2.9% (0.6)Basic and diluted earnings per share were EUR 0.24 (0.27)The Board of Directors proposes a dividend of 0.17 EUR per share (0.15) to be distributed for the year 2023. The dividend is proposed to be paid in two installments. The proposed dividend is 71 % of the profit per share for the fiscal year 2023 (55).Tapio Pajuharju assumed his role as CEO of Kamux on June 1, 2023. Kamux’s founder and previous CEO Juha Kalliokoski stepped down from the Company’s operative management on June 30, 2023.

Key Figures

EUR million

10−12/2023

10−12/2022

Change, %

1−12/2023

1−12/2022

Change, %

Revenue

241.6

222.9

8.4 %

1,002.1

968.7

3.5 %

Gross profit

26.1

21.2

23.4 %

102.5

94.1

9.0 %

as percentage of revenue, %

10.8 %

9.5 %

10.2 %

9.7 %

Operating profit (EBIT)

4.5

1.6

176.9 %

15.8

17.0

-7.1 %

as percentage of revenue, %

1.9 %

0.7 %

1.6 %

1.8 %

Adjusted operating profit*

5.5

2.1

164.1 %

18.0

17.5

3.2 %

as percentage of revenue, %

2.3 %

0.9 %

1.8 %

1.8 %

Revenue from integrated services

15.4

15.3

0.6 %

53.0

52.9

0.2 %

as percentage of revenue, %

6.4 %

6.9 %

5.3 %

5.5 %

Number of cars sold

16,354

14,681

11.4 %

68,257

62,922

8.5 %

Gross profit per sold car, EUR

1,597

1,442

10.8 %

1,502

1,495

0.5 %

Sales growth of like-for-like showrooms, %

8.2 %

-10.9 %

2.9 %

0.6 %

Net debt

53.8

59.1

-9.0 %

Inventories

117.2

114.1

2.7 %

Inventory turnover, days

46.9

51.5

-8.9 %

Capital expenditures

0.6

0.7

-13.2 %

1.8

3.1

-42.9 %

Average number of employees during the period

885

883

0.2 %

Return on equity (ROE), %

8.7 %

10.1 %

Return on investment (ROI), %

6.6 %

7.2 %

Equity ratio, %

51.9 %

53.2 %

Earnings per share, basic and diluted, EUR

0.06

0.00

1473.2 %

0.24

0.27

-11.6 %

*) Operating profit adjusted for special items related to strategic planning, legal processes, taxes from previous financial years, own real estate operations and other items, totaling EUR 1.0 million for the fourth quarter of 2023 and totaling EUR 2.2 million for 1−12/2023 (10-12/2022: EUR 0.5 million and 1−12/2022: EUR 0.4 million).

CEO Tapio Pajuharju:

“The used car market stabilized in all operating countries during 2023 and demand developed in a positive direction. However, volumes were still at a lower level than in 2021. It is great that despite the challenging early part of the year, we succeeded in our most important goal, i.e. improving our profitability. I am particularly pleased about our success in Finland, where the entire second half of the year was commercially excellent, and where we have further strengthened our market position. In Sweden, we continue to work to improve profitability, but even there our systematic work brought results and gross profit developed positively. In Germany, we opened two new showrooms in areas new to us during the year.

During the year, we also succeeded in reversing the trend in the volume of cars sold and sold a total of more than 68,000 cars (+8.5%), of which 16,354 in the last quarter of the year (+11.4%). In Finland, both Q3 and Q4 were all-time-high quarters in terms of the number of cars sold. In Sweden, the market was challenging and our focus on improving profitability was to some extent reflected in the decreasing number of cars sold. In Germany, the number of cars sold grew strongly, even though the second new showroom was only opened at the very end of the year and the market development in our core region of Schleswig-Holstein was significantly weaker than in the entire country.

With the strong development of our Finnish operations, we also reached an important milestone as our annual revenue exceeded one billion euros, marking an increase of 3.5% from the previous year. In the last quarter of the year, our revenue grew by 8.4% and was EUR 242 million. The price level of used cars remained stable during the year but prices continued to be at a lower level than in the previous year, which is also reflected in the revenue growth percentages.

At the end of the year, the purchasing market was normal in all operating countries. Despite the easing of inflation, consumers were still quite cautious and were generally looking for more affordable and economical cars. The electrification of the car fleet progressed in 2023, but e.g. the development of electricity and fuel prices and changes in the prices of new cars affected the demand for rechargeable used cars, as many consumers hesitated in their decisions and postponed the purchase of a car while waiting for more information. The number of plug-in hybrids and EV’s sold by Kamux increased by 67% in the fourth quarter compared to the corresponding period of the previous year and by 32% for the whole year.

I am particularly pleased with the gross profit development, and we’ve done great systematic work to improve the gross profit, especially in Finland and Sweden. As a result of the good gross profit development, our adjusted operating profit developed positively despite being burdened by e.g. increased sales incentives following the good development in the number of cars sold and car margin. In addition, the operating profit was burdened by costs related to opening new showrooms in Germany and the significant investments in the processing of cars and customer service that were begun in the third quarter. The operating profit was also negatively impacted by the increased costs resulting from the capacity increase in Sweden, especially as the capacity has not been brought to full productivity. In addition, we have identified misconduct in our Swedish operations. Corrective measures in relation to misconduct are ongoing. The Group’s adjusted operating profit was EUR 5.5 million (+164%) in the fourth quarter and EUR 18.0 million (+3.2%) for the whole year. Operating cash flow was strong, considering the season.

The first eight months as the CEO of Kamux have been dynamic and rewarding. I would like to offer warm thanks to the skilled and motivated Kamux employees for their good work and continuous improvement. I would also like to thank all our customers and partners for their trust. The maintenance measures and updates of the Kamux concept have progressed as planned and we will continue them in 2024. Our strategy update is also in its final stages, and we will publish our updated strategy at the Capital Markets Day on March 20. Welcome!”

Outlook for the year 2024

Kamux expects its adjusted operating profit for 2024 to exceed its 2023 adjusted operating profit, which was EUR 18.0 million.

Long-term targets

Kamux will publish its updated strategy and long-term targets on Wednesday, March 20, 2024.

Significant events after the reporting period

On January 22, 2024, Kamux announced that the Board of Directors of Kamux Corporation had resolved to establish a matching share plan for the recognized rising key employees of the Group. The Green Lions Plan 2024–2029 includes four (4) matching periods, covering the years 2024–2026, 2025–2027, 2026–2028 and 2027–2029. The prerequisite for participation in the plan and receiving a reward is that a participant has personally acquired Kamux shares within the limits set by the Board of Directors. Furthermore, payment of the reward is based on the participant’s valid employment contract upon reward payment. The target group of the first matching period of January 1, 2024 – December 31, 2026, consists of approximately 70 recognized future key employees, who are not included in Kamux’s other share-based incentive plans. The rewards to be paid on the basis of the plan correspond to the value of an approximate maximum total of 270,000 Kamux Corporation shares (estimated using the closing share price of January 17, 2024, EUR 5.23), including also the proportion to be paid in cash. The rewards from the first matching period will be paid by the end of March 2027.

On January 26, 2024, Kamux announced the Shareholders’ Nomination Board’s proposals for the Annual General Meeting 2024. The Shareholders Nomination Board proposes that the company’s Board of Directors shall have seven (7) members, and that the current members Juha Kalliokoski, Terho Kalliokoski, Antti Mäkelä, Harri Sivula and Jaana Viertola-Truini be re-elected as members of the Board of Directors and Maren Kroll and Kati Riikonen be elected as new members of the Board of Directors. Additionally, the Shareholders’ Nomination Board proposes to the AGM that Terho Kalliokoski be re-elected as Chairperson of the Board of Directors and Harri Sivula be re-elected as Vice Chairperson of the Board of Directors. According to the evaluation made by the nominees themselves and by the Shareholders’ Nomination Board, Juha Kalliokoski is dependent of both the company and its significant shareholders whilst the other nominees are independent of the company and of its significant shareholders. In addition, the Shareholders’ Nomination Board proposes to the AGM that the annual remuneration of the members of the Board of Directors and the committee fees be modestly raised.

On February 1, 2024, Kamux announced that a total of 2,092 Kamux Corporation’s shares had been returned free of consideration to Kamux Corporation in accordance with the terms and conditions of the Corporation’s share-based incentive scheme 2020 and 2021. After the return, Kamux Corporation held a total of 9,053 own shares.

On March 1, 2024, Kamux announced that the Board of Directors of Kamux Corporation has decided to approve a new long-term incentive Plan for the Group’s key persons for 2024–2026. The Plan commences at the beginning of 2024 and it is divided into three one-year performance periods. For the 2024 performance period, the payment of the potential reward from the Plan is based on exceeding the company’s operating profit threshold set by the Board of Directors, as well as on the development of earnings per share (ESP) and total shareholder return (TSR) and exceeding a certain ESG target indicator on an annual basis. The Board of Directors has selected 38 key persons, including the CEO, to participate in the Plan. In accordance with the terms and conditions of the Plan, the Board of Directors may decide during the performance period on the admission of new participants to the Plan. If a participant’s employment or service ends before the reward payment, the reward will not, as a general rule, be paid. If the maximum targets set for the performance criteria of the performance period 2024 are reached, the total amount of rewards to be paid based on the Plan for the performance period 2024 is approximately EUR 2.5 million (gross), corresponding to an estimated maximum of approximately 456,000 Kamux shares, when the value is calculated based on the volume-weighted average share price of Kamux’s share in January 2024. In addition, the Board of Directors has resolved that the long-term share-based incentive plan for 2023–2026 for CEO Tapio Pajuharju, that was announced on June 21, 2023, will be discontinued as of January 1, 2024, and that CEO Tapio Pajuharju will participate in the company’s new share-based incentive plan described above as of January 1, 2024. The Board of Directors has decided on a fixed maximum reward for the CEO for the performance period 2024. The maximum reward to be paid for the performance period 2024 is a maximum of 123,000 shares.

Kamux Corporation’s financial reporting and AGM in 2024

Publication schedule for Kamux Corporation’s financial reporting in 2024 is as follows:

Interim Report for January—March 2024                   May 17, 2024Half-Year Report for January—June 2024                 August 16, 2024Interim Report for January—September 2024           November 8, 2024

The Annual Report for 2023 including Financial Statements will be published on the week commencing March 25, 2024.

The Annual General Meeting of Kamux Corporation is scheduled to be held on April 18, 2024.

News conference

News conference for investors, analysts and media will be held today, Friday, March 1, 2024, at Sanomatalo, Flik Studio Eliel, 1st floor, Töölönlahdenkatu 2, Helsinki at 11:00 EET in English. CEO Tapio Pajuharju and CFO Jukka Havia will present the Financial Statements.

The conference can be followed as a live webcast at https://kamux.videosync.fi/q4-2023

Participation by conference call:

You can access the teleconference by registering on the link below. After the registration you will be provided phone numbers and a conference ID to access the conference. If you wish to ask a question, please dial *5 on your telephone keypad to enter the queue.
https://palvelu.flik.fi/teleconference/?id=50048520
 

For further information, please contact:
CEO Tapio Pajuharju, tel. +358 50 577 4200 
CFO Jukka Havia, tel. +358 50 355 3757
Head of Communications & IR Katariina Hietaranta, tel. +358 50 557 6765  

Kamux Corporation
Communications

Kamux is a retail chain specialized in used cars and related integrated services that has grown rapidly. Kamux combines online shopping with an extensive showroom network to provide its customers with a great service experience anytime, anywhere. In addition to digital channels, the company has a total of 78 car showrooms in Finland, Sweden and Germany. Since its founding in Hämeenlinna, Finland, in 2003 the company has sold over 500,000 used cars, 68,257 of which were sold in 2023. Kamux’s revenue in 2023 was EUR 1,002 million and its average number of employees was 885 in terms of full-time equivalent employees. Kamux Corporation is listed on Nasdaq Helsinki Ltd. For more information, please visit www.kamux.com  

The following files are available for download:

https://mb.cision.com/Main/17647/3938789/2639902.pdf

Kamux Corporation_Financial Statements Bulletin_2023

 

View original content:https://www.prnewswire.co.uk/news-releases/kamux-corporations-financial-statements-bulletin-for-january-1december-31-2023-revenue-grew-and-adjusted-operating-profit-increased-significantly-during-the-fourth-quarter-302076869.html

Related Topics:
Continue Reading

Technology

Brightmoor Hospice, LLC Provides Notification of Data Security Incident

Published

52 minutes ago

on

October 17, 2026

By

GRIFFIN, Ga., Oct. 16, 2026 /PRNewswire/ — Brightmoor Hospice, LLC (“Brightmoor”) is providing notification of a data security incident that may have impacted certain protected health information.

On or around March 25, 2026, Brightmoor Hospice, LLC (“Brightmoor”) discovered suspicious activity related to two employees’ email accounts. Upon discovery, Brightmoor took immediate action to secure the accounts and engaged a team of third-party specialists to investigate. The investigation determined that two employee email accounts were accessed without authorization between March 24, 2026, and March 25, 2026. Upon confirmation of unauthorized access, Brightmoor began a comprehensive review of the contents of the affected accounts to determine whether they contained sensitive information pertaining to individuals. On August 18, 2026, Brightmoor determined that protected health information belonging to certain patients was present within the accounts. Brightmoor then conducted a time-intensive review of its internal records to locate address information for the potentially impacted individuals. On October 16, 2026, Brightmoor began notifying individuals by mail.

The types of information vary by individual and may include name and one or more of the following: addresses, Social Security numbers, driver’s license information, dates of birth, patients’ identification numbers, diagnosis, medical history information, medical record numbers, medical treatment information, lab information, treating doctor’s name, medication information, vaccination information, medical insurance information, and family and social history information.

In response to this incident, Brightmoor worked with third-party specialists to investigate and implement additional security measures within its network. Brightmoor has no evidence of actual or attempted misuse of information as a result of this incident. Nonetheless, in an abundance of caution, Brightmoor is providing notice to potentially affected individuals and offering complimentary credit monitoring services. Individuals are also encouraged to monitor their account statements and explanation of benefits forms for suspicious activity and to detect errors. In addition, Brightmoor has notified the U.S. Health and Human Services Office for Civil Rights of this incident. 

Brightmoor has established a toll-free call center to answer questions about the incident and to address related concerns. The number for the hotline is 1-800-759-8524. The hotline hours of operation are Monday through Friday from 8 AM to 8 PM EST, excluding holidays. You can also write to 3247 Newnan Rd, Griffin, GA 30223.

Brightmoor takes protecting the privacy and security of personal information seriously and is reviewing and implementing further security enhancements designed to strengthen the protection of our systems.

View original content:https://www.prnewswire.com/news-releases/brightmoor-hospice-llc-provides-notification-of-data-security-incident-302911735.html

SOURCE Brightmoor Hospice, LLC

Continue Reading

Technology

EVIDENT Expands Its Pramana Digital Pathology Portfolio to Support Small and Medium-Sized Labs

Published

2 hours ago

on

October 17, 2026

By

The new Pramana™ POD benchtop WSI scanner delivers autonomous imaging to help laboratories create pathologist-ready whole slide images with minimal operator intervention.

NEEDHAM, Mass., Oct. 16, 2026 /PRNewswire/ — Today, Evident announced the Pramana™ POD whole slide imaging (WSI) scanner, a new benchtop system designed to help laboratories produce trusted images. Built for small and medium-sized laboratories and specialty applications within larger institutions, the scanner helps make digital pathology adoption more accessible.

As pathology laboratories expand digital workflows amid increasing case volumes and operational demands, they need scanning systems that produce consistent, high-quality images across specimen types while integrating into existing laboratory workflows. Evident designed the Pramana POD scanner to address those needs, extending proven Pramana autonomous WSI technology to smaller laboratories.

“Pramana WSI technology has received tremendous acceptance from pathology labs across academic medical centers and network labs across the United States,” said Prasanth Perugupalli, Vice President of Digital Pathology, Evident. “By incorporating quality assurance into the whole slide imaging process, Pramana technology can help labs of varying sizes reduce the need for post-scan QA and the associated costs and delays.”

The Pramana POD scanner automates imaging with an advanced tissue finder, extensive label detection, and automated focal plane and scan-profile selection. Built-in image-quality assessment helps deliver pathologist-ready whole slide images and identify scans that may require further review. Volumetric imaging captures multiple focal planes to support the selection of sharp focal information across the scanned area, with true 40X imaging at 25 slides per hour under defined conditions.

The Pramana series of autonomous WSI scanners is well-suited for most brightfield imaging applications, including histopathology, core biopsies, hematology, cytology, and microbiology.

“Scientific advances move quickly, but laboratory infrastructure changes slowly,” Perugupalli added. “With the Pramana POD scanner, small and medium-sized labs can build as their needs evolve.”

To learn more about the Pramana POD benchtop WSI scanner, visit evidentscientific.com/products/slide-scanners/pramana-pod.

About EVIDENT
For over 100 years as Olympus, we set the industry standard for optical precision in microscopy, helping the world see what was once out of view. Today, as Evident, we continue to help scientists, physicians, and engineers illuminate the unseen with advanced imaging solutions that combine renowned optics with cutting-edge digital innovation.

Our life science portfolio supports research, clinical diagnostics, and education, offering a comprehensive range of imaging methods from essential brightfield and darkfield microscopy to advanced fluorescence, 4D analysis, and digital pathology. In industrial microscopy, we deliver precision and flexibility through laser scanning, digital, and semiconductor microscopes designed for tasks ranging from routine inspection to intricate quality control and manufacturing analysis.

Whether advancing new therapies, ensuring product integrity, or exploring the unknown, Evident is defining a new era of discovery with easy-to-use tools that help unlock hidden answers and empower exciting new breakthroughs.

Evident is headquartered in Tokyo and supported by R&D and manufacturing centers in Japan, the United States, Germany, and China, with operations and dedicated sales and service centers around the world. For more information, visit EvidentScientific.com.

For Research Use Only. Not for use in diagnostic procedures. Future clinical availability is subject to applicable regulatory authorization, and regulatory status and availability may vary by country. Performance varies by specimen type and workflow.
Pramana is a trademark of Evident Corporation or its subsidiaries.

View original content to download multimedia:https://www.prnewswire.com/news-releases/evident-expands-its-pramana-digital-pathology-portfolio-to-support-small-and-medium-sized-labs-302911714.html

SOURCE Evident

Continue Reading

Technology

PhotonPay Secures UK EMI Licence, Advancing Its Global Payment Operating System

Published

2 hours ago

on

October 17, 2026

By

HONG KONG, Oct. 17, 2026 /PRNewswire/ — PhotonPay, a next-generation payment operating system, today announced that it has secured an Electronic Money Institution (EMI) licence from the UK Financial Conduct Authority (FCA).

The licence enables PhotonPay to issue electronic money and provide regulated payment services in the UK within the scope of its authorisation. It further strengthens PhotonPay’s local capabilities in the market and supports the company in delivering broader payment and treasury solutions for businesses operating globally.

The UK is one of the world’s leading financial and commercial hubs, and an important gateway for businesses operating across Europe and international markets. As companies expand into more countries and regions, their financial needs are evolving beyond individual cross-border transactions toward more integrated management of accounts, collections, payouts, foreign exchange, cards and treasury operations.

For PhotonPay, entering a market means more than making products and services available. It requires building a local financial foundation that meets regulatory requirements and can support businesses over the long term. The EMI licence further strengthens PhotonPay’s position in the UK and provides an important foundation for deeper connectivity with local banks, payment networks and the broader financial ecosystem.

JP, Global Head of Compliance at PhotonPay, said:

“Securing our UK EMI licence marks an important milestone in the continued expansion of PhotonPay’s global regulatory footprint. Building a global payment operating system requires strong local regulatory foundations. This authorisation strengthens our ability to build for the long term in the UK, while supporting our continued expansion across more markets, currencies and payment networks. Ultimately, it enables us to deliver a more complete and efficient payment and treasury experience for businesses operating globally.”

As businesses expand internationally, the financial infrastructure behind their operations remains highly fragmented. Different markets operate across distinct account structures, payment networks, currencies and regulatory frameworks, often requiring businesses to manage multiple financial institutions, payment providers and systems at the same time.

PhotonPay is building its next-generation payment operating system around this complexity. Through a unified technology platform, the company connects local financial capabilities across markets, enabling businesses to manage global accounts, collections, payouts, foreign exchange, cards and embedded finance more centrally while reducing the operational complexity created by multiple markets, currencies and systems.

Real commerce is the foundation of this operating system. By continuously expanding its regulatory coverage, banking relationships, payment networks and underlying technology infrastructure, PhotonPay aims to ensure that financial infrastructure can scale alongside a business as it enters new markets and grows internationally.

Since its founding, PhotonPay has continued to expand its global regulatory and local market capabilities through entities across major financial markets. Today, PhotonPay has secured nearly 30 payment licences and related regulatory authorisations worldwide, supporting capabilities across global accounts, collections, payouts, foreign exchange, cards and embedded finance.

The UK EMI licence represents another step in the continued development of PhotonPay’s global regulatory network. Looking ahead, PhotonPay will continue to deepen its local regulatory and financial capabilities in key markets, connect more markets, currencies and payment networks, and advance the development of its next-generation global payment operating system.

About PhotonPay

PhotonPay is a next-generation payment operating system designed for businesses operating globally. Across global accounts, collections, payouts, foreign exchange, cards and embedded finance, PhotonPay connects banks, payment networks and local financial infrastructure to help businesses manage global money movement more efficiently and expand into new markets with greater operational simplicity.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/photonpay-secures-uk-emi-licence-advancing-its-global-payment-operating-system-302911540.html

SOURCE PhotonPay

Continue Reading

Trending